Market Cap 520,000.00
Revenue (ttm) 0.00
Net Income (ttm) -124.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.18
Volume 1,300
Avg Vol 11,688
Day's Range N/A - N/A
Shares Out 4.52M
Stochastic %K 0%
Beta 1.30
Analysts Strong Buy
Price Target $45.00

Company Profile

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly know...

Phone: 833 727 2841
Address:
4330 La Jolla Village Drive, Suite 300, San Diego, United States
Latest News on BIORQ
No data available.